Exelixis (NASDAQ:EXEL) Stock Price Expected to Rise, Citigroup Analyst Says
Exelixis (NASDAQ:EXEL – Free Report) had its price objective increased by Citigroup from $45.00 to $56.00 in a research note issued to investors on Thursday morning,Benzinga reports. The firm currently has a buy rating on the biotechnology company’s stock. Other equities research analysts have also issued research reports about the stock. Oppenheimer lowered shares of […]
Exelixis (NASDAQ:EXEL – Free Report) had its price objective increased by Citigroup from $45.00 to $56.00 in a research note issued to investors on Thursday morning,Benzinga reports. The firm currently has a buy rating on the biotechnology company’s stock. Other equities research analysts have also issued research reports about the stock. Oppenheimer lowered shares of […]
